|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/06 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 31/4166 | (2013.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 31/454 | (2013.01) | ||
| A61K 31/4166 | (2006.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61K 31/4035 | (2006.01) | ||
| A61K 31/4035 | (2013.01) |
| (11) | Number of the document | 3357513 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16850363.9 |
| Date of filing the European patent application | 2016-09-28 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2016/100642 |
| Date | 2016-09-28 |
| (87) | Number | WO 2017/054739 |
| Date | 2017-04-06 |
| (30) | Number | Date | Country code |
| 201510631654 | 2015-09-29 | CN |
| (72) |
GE, Chuansheng , CN
LIAO, Baisong , CN
LEE, Wen-Cherng , CN
|
| (73) |
Kangpu Biopharmaceuticals, Ltd. ,
780 Cailun Road, Suite 818
Zhangjiang Hi-Tech Park
Pudong New Area, Shanghai 201203,
CN
|
| (54) | PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF |
| PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF |